Drug
Anumigilimab
Anumigilimab: highest development phase Phase 2, developed by CSL. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- CSL
Trials
| Drug | Phase | Indication |
|---|---|---|
| Anumigilimab NCT07224360 | Phase 2 | Sickle Cell Disease |
Latest
No recent events.
Follow Anumigilimab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.